Adam E. Snook, PhD
I'm an Assistant Professor in the Department of Pharmacology and Experimental Therapeutics at the Thomas Jefferson University Sidney Kimmel Cancer Center. My research has two primary focuses: 1) understanding intestinal biology and tumorigenesis to prevent colorectal cancer and 2) developing new cancer immunotherapies. We also believe strongly in training the next generation of scientists and welcome PhD, MD/PhD, and MS students and post-docs to train with our group.
My undergraduate training was in Pharmacology and Toxicology at the University of the Sciences in Philadelphia, PA. I then earned a PhD in Immunology and Microbial Pathogenesis from Thomas Jefferson University in Philadelphia, PA. My dissertation work identified GUCY2C (guanlylyl cyclase C) as a novel target for colorectal cancer therapy. I am now studying the role of GUCY2C in intestinal biology and colorectal cancer pathophysiology, developing GUCY2C-targeted immunotherapies including cancer vaccines and CAR-T cell therapies, and studying the interaction between the immune system and a number of cancers.